Alice I. Nichols, PhD | Psychiatrist.com

Article

How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example

March 19, 2015

How do you avoid drug-drug interactions in your patients who are taking multiple medications? This article explains the process for assessing the risk of a drug causing or being...

Matthew Macaluso, Alice I. Nichols, Sheldon H. Preskorn

Original Research

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression: Implications for Personalized Medicine

March 13, 2013

Sheldon H. Preskorn, Cecelia P. Kane, Kasia Lobello, et al

Original Research

Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine: A Secondary Analysis of 4 Studies in Major Depressive Disorder

April 13, 2010

Kasia W. Lobello, Sheldon H. Preskorn, Christine J. Guico-Pabia, et al